Skip to content
Open access

Soluble ST2 dynamics are associated with delayed hospital discharge in COVID-19 patients: a joint-modeling analysis of the DisCoVeRy trial's longitudinal data.

Aug 2026 · Clinical Microbiology and Infection · 0 citations · 33 references
Medicine

TL;DR

Longitudinal sST2 dynamics were associated with delayed hospital discharge before day 29 and provided better prognostic information than D-dimer, suggesting sST2 may serve as a biomarker of impaired recovery and a potential tool for risk stratification and clinical decision support.

Abstract

Objectives

Identifying robust biomarkers reflecting thromboinflammation, endothelial injury, angiogenesis, and fibrosis that predict clinical recovery remains challenging. Although several biomarkers are associated with disease severity, the added value of their longitudinal dynamics beyond established markers is unclear. We assessed the association between biomarker trajectories and time to hospital discharge in hospitalized patients with COVID-19.

Methods

We analyzed hospitalized adults with PCR-confirmed SARS-CoV-2 infection enrolled in the DisCoVeRy randomized trial. Blood samples were collected at baseline and days 3, 5, 8, and 11 to measure D-dimer and 12 biomarkers. The primary outcome was time to hospital discharge by day 29, with death as a competing risk. Bayesian joint models combining linear mixed-effects models for biomarker trajectories and cause-specific Cox models were adjusted for baseline severity, ISARIC 4C score, and treatment arm. Models included D-dimer alone and each biomarker added individually. Results are reported as adjusted hazard ratios (aHR) with 95% credibility intervals (CrI).

Results

Of the 603 participants randomized, 492 had at least one sample measured, 32% (155/492) had a severe disease, and 5.5% (27/492) died before day 29. Of all biomarkers, only soluble ST2 (sST2) was still associated with time-to-discharge in multivariate analysis after adjusting baseline covariates (aHR: 0.26, 95% CrI: [0.17-0.41], P<10-4). A level of sST2 twice as high leads to a 33% (95% CrI: [24%;41%]) lower instantaneous probability of discharge. D-dimer was significantly associated with time-to-discharge in the null model (0.37 [0.23-0.58], P<10-4), but not when including sST2 (0.68 [0.42-1.07], P=0.09).

Conclusion

Longitudinal sST2 dynamics were associated with delayed hospital discharge before day 29 and provided better prognostic information than D-dimer. By integrating signals of inflammation, endothelial injury, and tissue remodeling, sST2 may serve as a biomarker of impaired recovery and a potential tool for risk stratification and clinical decision support. External validation by prospective studies is needed to confirm our findings.

Read PDF

Similar papers

Open access Aug 2026

Integrated Inflammatory, Thrombo-Inflammatory, Redox and Soluble IFNAR2 Profiling During Hospitalization for COVID-19: An Exploratory Observational Cohort Study

Background: Severe COVID-19 reflects a multi-layered host response with systemic inflammation, thrombo-inflammation, tissue damage, oxidative stress and altered antiviral interferon biology. We performed an integrated exploratory analysis of first-wave hospitalized patients to identify biomarker patterns associated wit...

Álvaro Martínez Mesa, Eva B. Cabrera Cesar, María García-Fernández et al. · 0 citations
Open access Sep 2026

SARS-CoV-2 infection and two-year longitudinal clinical trajectory in pulmonary hypertension: a single-center retrospective exploratory cohort study

Introduction SARS-CoV-2 may promote endothelial injury, pulmonary vascular inflammation, and thrombosis, mechanisms relevant to pulmonary hypertension (PH), but longitudinal post-COVID-19 trajectories in established PH remain poorly defined. Methods We retrospectively analysed 40 PH patients in the prospectively establ...

A. Al-Qahtani, F. Alzubi, D. Obeid et al. · 0 citations
Open access Sep 2026

Longitudinal sepsis-induced coagulopathy score trajectories and mortality in relation to early prophylactic heparin: a multicentre cohort study

Background Sepsis-induced coagulopathy (SIC) evolves dynamically, and a single-timepoint score may not capture its longitudinal course. This study characterised SIC score trajectories, evaluated their associations with mortality, and conducted exploratory analyses of early prophylactic unfractionated heparin exposure....

Yuan Cao, Min Wang, Yun Li et al. · 0 citations
Open access Sep 2026

Routine Biomarkers for COVID-19 Mortality Prediction in Low-Resource Settings

COVID-19 has placed a heavy burden on healthcare systems, especially in resource limited settings where simple and affordable tools are needed to identify patients at high risk of death. This study aimed to evaluate routine laboratory biomarkers associated with mortality among hospitalized COVID-19 patients. A retrospe...

Danis Pertiwi, Rahayu, A. Aulia et al. · 0 citations
Open access Oct 2026

Identification and validation of early vital sign trajectory subphenotypes for risk stratification in sepsis-associated liver injury: a multicenter retrospective cohort study

Sepsis-associated liver injury (SALI) is a serious clinical syndrome with heterogeneity in outcome among affected individuals. Physiological changes that are critical to outcome prediction are not considered in the existing system of stratification based on single-point observations. This could compromise the effec...

Wei-Hang Wang, Jing Ma, Bing-Qi Wang et al. · 0 citations
Open access Aug 2026

Persistent mitochondrial and endothelial dysfunction in non-hospitalized patients with Long COVID

Serum levels of growth differentiation factor 15, a mitochondrial stress marker, and vascular cell adhesion molecule-1, a vascular endothelial stress marker are evaluated in 32 patients with Long COVID who presented with persistent systemic or neurological symptoms and had not required acute-phase hospitalization to su...

Rie Ono, Shin Takayama, Michiaki Abe et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.